These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 786685)

  • 21. Pharmacokinetic consequences of plasma protein binding of drugs.
    Schoenemann PT; Yesair DW; Coffey JJ; Bullock FJ
    Ann N Y Acad Sci; 1973 Nov; 226():162-71. PubMed ID: 4520393
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug interactions and clinical pharmacokinetics.
    Kristensen MB
    Clin Pharmacokinet; 1976; 1(5):351-72. PubMed ID: 797504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualization of drug dosage--past, present and future.
    Thomson AH
    Med Monatsschr Pharm; 2003 May; 26(5):150-2. PubMed ID: 12784502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.
    Klockowski PM; Levy G
    J Pharm Sci; 1987 Jul; 76(7):516-20. PubMed ID: 3668811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized Drug Dosage - Closing the Loop.
    Tucker GT
    Pharm Res; 2017 Aug; 34(8):1539-1543. PubMed ID: 27943015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising in vivo pharmacology studies--Practical PKPD considerations.
    Gabrielsson J; Green AR; Van der Graaf PH
    J Pharmacol Toxicol Methods; 2010; 61(2):146-56. PubMed ID: 20153442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rational posology and drug dosage].
    Riant P; Albengres E; Barre J; Tillement JP
    Ann Biol Clin (Paris); 1986; 44(1):15-24. PubMed ID: 3518550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothesis for the individualisation of drug dosage.
    Koup JR; Sack CM; Smith AL; Gibaldi M
    Clin Pharmacokinet; 1979; 4(6):460-9. PubMed ID: 519932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions and the elderly.
    Reidenberg MM
    J Am Geriatr Soc; 1982 Nov; 30(11 Suppl):S67-8. PubMed ID: 7130590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose individualization in PharmDIS-e+.
    Proost JH; Punt NC
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):451-8. PubMed ID: 14703950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review on correlation between pharmacologic response and drug disposition.
    Ritschel WA; Hussain A
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):627-40. PubMed ID: 6392792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug therapy. Serum drug concentrations as therapeutic guides.
    Koch-Weser J
    N Engl J Med; 1972 Aug; 287(5):227-31. PubMed ID: 5037497
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma protein binding: from discovery to development.
    Bohnert T; Gan LS
    J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric clinical pharmacology and the "therapeutic orphan".
    Done AK; Cohen SN; Strebel L
    Annu Rev Pharmacol Toxicol; 1977; 17():561-73. PubMed ID: 326173
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosage regimen design: pharmacodynamic considerations.
    Williams RL
    J Clin Pharmacol; 1992 Jul; 32(7):597-602. PubMed ID: 1639996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma/serum protein binding determinations.
    Banker MJ; Clark TH
    Curr Drug Metab; 2008 Nov; 9(9):854-9. PubMed ID: 18991581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.
    Boissel JP; Nony P
    Clin Pharmacokinet; 2002; 41(1):1-6. PubMed ID: 11825093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.
    Chiou WL
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):527-36. PubMed ID: 529021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.